Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy
- Author
- WRIGHT, G1 ; COLMAN, A1 ; COTTOM, D1 ; WILLIAMS, M1
[1] PPL Therapeutics, Roslin, Edinburgh, Scotland, United Kingdom - Conference title
- Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium
- Conference name
- Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium (Bethesda, Maryland 1995-06-14)
- Author (monograph)
- BROWN, Fred (Editor)1 ; LUBINIECKI, A (Editor)2
Food and Drug Administration FDA, Washington DC, United States (Funder/Sponsor)
International Association of Biological Standardization IABS, International (Funder/Sponsor)
National Institute of Allergy and Infectious Diseases NIAID (Funder/Sponsor)
U.S. Department of Agriculture USDA, United States (Funder/Sponsor)
National Vaccine Program Office NVPO (Funder/Sponsor)
[1] Plum Island Disease Center, Greenport NY, United States
[2] SmithKline Beecham Pharmaceuticals, King of Prussia PA, United States - Source
Developments in biological standardization. 1996, Num 88, pp 269-276
- CODEN
- DVBSA3
- ISSN
- 0301-5149
- Scientific domain
- Biochemistry, molecular biology, biophysics; Microbiology, infectious diseases
- Publisher
- Karger, Basel
/
Karger, München
/
Karger, Paris
- Publication country
- Switzerland
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Animal transgénique Contamination biologique Elimination Microorganisme Méthode Protéine recombinante
- Keyword (en)
- Transgenic animal Biological contamination Elimination Microorganism Method Recombinant protein
- Keyword (es)
- Animal transgénico Contaminación biológica Eliminación Microorganismo Método Proteína recombinante
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A31 Biotechnology / 002A31D Industrial applications and implications. Economical aspects / 002A31D01 Health. Pharmaceutical industry / 002A31D01C Production of active biomolecules / 002A31D01C8 Other active biomolecules
- Discipline
- Biotechnology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2508838
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Developments in biological standardization\";s:9:\"\u0000*\u0000stitle\";s:16:\"Dev. biol. stand\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"88\";s:8:\"\u0000*\u0000spage\";s:3:\"269\";s:8:\"\u0000*\u0000epage\";s:3:\"276\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0301-5149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"WRIGHT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"COLMAN, A\";i:1;s:9:\"COTTOM, D\";i:2;s:11:\"WILLIAMS, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DVBSA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:89:\"Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium\";s:8:\"\u0000*\u0000title\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Developments in biological standardization\";s:9:\"\u0000*\u0000stitle\";s:16:\"Dev. biol. stand\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"88\";s:8:\"\u0000*\u0000spage\";s:3:\"269\";s:8:\"\u0000*\u0000epage\";s:3:\"276\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0301-5149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"WRIGHT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"COLMAN, A\";i:1;s:9:\"COTTOM, D\";i:2;s:11:\"WILLIAMS, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DVBSA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:89:\"Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium\";s:8:\"\u0000*\u0000title\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Developments in biological standardization\";s:9:\"\u0000*\u0000stitle\";s:16:\"Dev. biol. stand\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"88\";s:8:\"\u0000*\u0000spage\";s:3:\"269\";s:8:\"\u0000*\u0000epage\";s:3:\"276\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0301-5149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"WRIGHT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"COLMAN, A\";i:1;s:9:\"COTTOM, D\";i:2;s:11:\"WILLIAMS, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DVBSA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:89:\"Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium\";s:8:\"\u0000*\u0000title\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Developments in biological standardization\";s:9:\"\u0000*\u0000stitle\";s:16:\"Dev. biol. stand\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"88\";s:8:\"\u0000*\u0000spage\";s:3:\"269\";s:8:\"\u0000*\u0000epage\";s:3:\"276\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0301-5149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"WRIGHT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"COLMAN, A\";i:1;s:9:\"COTTOM, D\";i:2;s:11:\"WILLIAMS, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DVBSA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:89:\"Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium\";s:8:\"\u0000*\u0000title\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Developments in biological standardization\";s:9:\"\u0000*\u0000stitle\";s:16:\"Dev. biol. stand\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"88\";s:8:\"\u0000*\u0000spage\";s:3:\"269\";s:8:\"\u0000*\u0000epage\";s:3:\"276\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0301-5149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"WRIGHT\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:9:\"COLMAN, A\";i:1;s:9:\"COTTOM, D\";i:2;s:11:\"WILLIAMS, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DVBSA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:89:\"Viral safety and evaluation of viral clearance from biopharmaceutical products. Symposium\";s:8:\"\u0000*\u0000title\";s:110:\"Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal: A strategy\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
